10/21/22 19:01  | 10/19/22  | MIST | Milestone Pharmaceuticals Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | A8 | D |  | P | 80 | 5.32 | 0 | 15 | New | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/21 20:00  | 8/6/21  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | M.d | 444 | 17.75 | 0 | 25 |  | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/21 20:00  | 8/6/21  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | S.d | -3,463 | 138.52 | 0 | -25 | -93 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/12/21 17:50  | 3/10/21  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | M.d | 0 | 0.00 | 0 | 3 |  | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/20 16:46  | 9/1/20  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | M.d | 213 | 17.75 | 0 | 12 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/20 16:46  | 9/1/20  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | S.d | -1,107 | 92.26 | 0 | -12 | -97 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/20 16:20  | 8/3/20  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | M.d | 213 | 17.75 | 0 | 12 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/20 16:20  | 8/3/20  | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Tomsicek Michael John | MA | O | CFO | S.d | -1,041 | 86.74 | 0 | -12 | -97 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/31/14 16:04  | 12/29/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 470 | 23.50 | 0 | 20 |  | 16 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/14 16:03  | 8/15/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 21 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/14 16:03  | 8/18/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S.d | -26 | 63.68 | 0 | 0 | -5 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/14/14 16:13  | 5/13/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 31 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/14/14 16:13  | 5/14/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S.d | -34 | 69.00 | 0 | 0 | -7 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/16/14 16:45  | 4/15/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 34 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/16/14 16:45  | 4/16/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S.d | -28 | 64.00 | 0 | 0 | -8 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/19/14 15:36  | 2/15/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.dm | 0 | 0.00 | 0 | 2 | 57 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/19/14 15:36  | 2/18/14  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S.d | -42 | 75.00 | 0 | -1 | -11 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/5/13 16:07  | 9/3/13  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S | -26 | 64.08 | 0 | 0 | -11 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/16/13 12:13  | 8/15/13  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 52 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/15/13 17:25  | 5/13/13  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 305 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/15/13 17:25  | 5/14/13  | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Tomsicek Michael John | MA | O | SVP,CFO | S.d | -24 | 49.18 | 0 | 0 | -20 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |